Senior Scientist
Princess Margaret Cancer Centre
University Health Network;
Chief Scientist
Structural Genomics Consortium, Toronto;
Professor
Department of Medical Biophysics
University of Toronto
Toronto, Ontario
Canada
For pioneering contributions to chemical biology and cancer epigenetics, including foundational studies defining the structure and function of chromatin-associated proteins that regulate gene expression in cancer. Dr. Arrowsmith’s work has enabled the development of chemical probes targeting epigenetic regulators such as protein methyltransferases, methyl-lysine ‘reader domains’, bromodomains, and other chromatin-modifying enzymes, providing critical tools to interrogate cancer biology. Through her leadership of the Structural Genomics Consortium, she has advanced open science approaches that have accelerated the discovery of novel therapeutic targets and strategies in cancer.
The AACR Award for Outstanding Achievement in Chemistry in Cancer Research was established in 2007 to recognize outstanding, novel, and significant chemistry research, which has led to important contributions in basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. To learn more please visit the press release.
View Past Recipients.